{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:40:29Z","timestamp":1785494429681,"version":"3.56.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Stomach adenocarcinoma (STAD) remains a major contributor to cancer-related mortality worldwide. Despite advances in immunotherapy, only a subset of STAD patients benefits from immune checkpoint inhibitors, largely due to tumor-intrinsic immune evasion mechanisms. Therefore, robust predictive biomarkers are urgently needed to guide prognosis assessment and therapeutic decision-making.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An integrative machine learning framework incorporating 10 algorithms was applied to construct an immune evasion signature (IES) using 101 model combinations. The optimal model was selected based on concordance index (C-index) across validation datasets. The prognostic and immunological relevance of the IES was assessed via survival analyses, immune infiltration deconvolution, and multiple immunotherapy response metrics. Key genes were further validated using qPCR, immunohistochemistry, and <jats:italic>in vitro<\/jats:italic> functional assays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A four-gene IES developed via the LASSO method demonstrated robust prognostic power across TCGA and multiple external cohorts. High IES score were associated with poor survival, reduced immune cell infiltration (e.g., CD8<jats:sup>+<\/jats:sup> T cells, dendritic cells), elevated M2 macrophage abundance, and an immunosuppressive tumor microenvironment. Patients in the low IES score group exhibited favorable immunotherapy-associated features, including higher TMB, lower TIDE scores, and increased response rates in three independent immunotherapy datasets. Additionally, the IES stratified patients by sensitivity to chemotherapy and targeted therapies. KLF16, one of the signature genes, was upregulated in STAD and promoted cancer cell proliferation <jats:italic>in vitro<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We established a novel IES with strong potential to predict prognosis and immunotherapy response in STAD. This IES may serve as a valuable tool for risk stratification and individualized treatment planning in clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcell.2025.1656367","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:30:23Z","timestamp":1758778223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Machine learning based immune evasion signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenwu","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12967-023-04033-6","article-title":"Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma","volume":"21","author":"Chang","year":"2023","journal-title":"J. Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12967-024-05134-6","article-title":"CD8(+) T cell-based cancer immunotherapy","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nmeth.1607","article-title":"A roadmap to generate renewable protein binders to the human proteome","volume":"8","author":"Colwill","year":"2011","journal-title":"Nat. methods"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0291645","DOI":"10.1371\/journal.pone.0291645","article-title":"Identification of M2-like macrophage-related signature for predicting the prognosis, ecosystem and immunotherapy response in hepatocellular carcinoma","volume":"18","author":"Feng","year":"2023","journal-title":"PloS one"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41590-024-01960-4","article-title":"The complexity of immune evasion mechanisms throughout the metastatic cascade","volume":"25","author":"Haynes","year":"2024","journal-title":"Nat. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1158\/2326-6066.CIR-20-0983","article-title":"TMB and inflammatory gene expression associated with clinical outcomes following immunotherapy in advanced melanoma","volume":"9","author":"Hodi","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","article-title":"Functional genomic landscape of cancer-intrinsic evasion of killing by T cells","volume":"586","author":"Lawson","year":"2020","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinforma. Oxf. Engl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic acids Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/ijmm.2022.5171","article-title":"Transcription factor KLF16 activates MAGT1 to regulate the tumorigenesis and progression of breast cancer","volume":"50","author":"Li","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"102897","DOI":"10.1016\/j.arcmed.2023.102897","article-title":"Machine learning-based integration develops a macrophage-related index for predicting prognosis and immunotherapy response in lung adenocarcinoma","volume":"54","author":"Li","year":"","journal-title":"Archives Med. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1201297","DOI":"10.3389\/fonc.2023.1201297","article-title":"Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival","volume":"13","author":"Li","year":"","journal-title":"Front. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","article-title":"CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases","volume":"74","author":"Li","year":"2025","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","first-page":"698677","DOI":"10.3389\/fimmu.2021.698677","article-title":"HLA-G\/ILTs targeted solid cancer immunotherapy: opportunities and challenges","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3389\/fimmu.2020.02039","article-title":"Crosstalk between the MSI status and tumor microenvironment in colorectal cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","article-title":"Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"833928","DOI":"10.3389\/fgene.2022.833928","article-title":"A necroptosis-related lncRNA-based signature to predict prognosis and probe molecular characteristics of stomach adenocarcinoma","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Briefings Bioinforma."},{"key":"B23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a cancer J. Clin."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.2147\/OTT.S342613","article-title":"Identification and validation a necroptosis-related prognostic signature and associated regulatory Axis in stomach adenocarcinoma","volume":"14","author":"Wang","year":"2021","journal-title":"OncoTargets Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12885-024-12302-w","article-title":"Comprehensive analysis of T-cell regulatory factors and tumor immune microenvironment in stomach adenocarcinoma","volume":"24","author":"Wang","year":"2024","journal-title":"BMC cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12935-025-03743-9","article-title":"Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma","volume":"25","author":"Wen","year":"2025","journal-title":"Cancer Cell. Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"965102","DOI":"10.3389\/fonc.2022.965102","article-title":"Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic acids Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","article-title":"Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development","volume":"10","author":"Yasuda","year":"2024","journal-title":"Trends cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"612952","DOI":"10.3389\/fonc.2021.612952","article-title":"A 13-gene metabolic prognostic signature is associated with clinical and immune features in stomach adenocarcinoma","volume":"11","author":"Ye","year":"2021","journal-title":"Front. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1069204","DOI":"10.3389\/fphar.2022.1069204","article-title":"Identification of TGF-\u03b2 signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.7150\/jca.106029","article-title":"Training and experimental validation a novel anoikis- and epithelial\u2012mesenchymal transition-related signature for evaluating prognosis and predicting immunotherapy efficacy in gastric cancer","volume":"16","author":"Zeng","year":"2025","journal-title":"J. Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2147\/OTT.S233495","article-title":"KLF16 affects the MYC signature and tumor growth in prostate cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"OncoTargets Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12935-023-03169-1","article-title":"The emerging role of glycolysis and immune evasion in gastric cancer","volume":"23","author":"Zheng","year":"2023","journal-title":"Cancer Cell. Int."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1656367\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:30:24Z","timestamp":1758778224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1656367\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":37,"alternative-id":["10.3389\/fcell.2025.1656367"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1656367","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"article-number":"1656367"}}